Nutriband Inc., a company primarily focused on the development of prescription transdermal pharmaceutical products, recently disclosed its completion of registration requirements to extend its Chinese ...

ORLANDO, Fla., Dec. 31, 2024 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders highlighting the ...

Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders highlighting the company's ...

Fentanyl, a synthetic opioid 50 times more powerful than heroin, has fueled a surge in fatal overdoses across Texas.